TrademarkDir
KYRIX
LIVE

Serial Number

97411368

Owner

Bridge Biotherapeutics Inc.

Attorney

Timur Slonim

Filing Date

May 15, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KYRIX Trademark

Serial Number: 97411368

KYRIX is a trademark filed by Bridge Biotherapeutics Inc. on May 15, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Bridge Biotherapeutics Inc. (4 trademarks)

55 Chapel Street, Suite 100
Newton,, MA 02458

Entity Type: 03

Trademark Details

Filing Date

May 15, 2022

Registration Date

Not Registered

Published for Opposition

December 31, 2024

Goods & Services

Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical drug discovery services; pharmaceutical and biopharmaceutical research services

Pharmaceutical and biopharmaceutical preparations, excluding vaccines for human use, for the treatment and prevention of cancer, fibrosis, and inflammatory diseases for therapeutical applications excluding prescription pharmaceutical and medicinal preparations for the treatment and prevention of kidney diseases and disorders, administered in any way other than topically, and excluding anti-inflammatories

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 17, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 17, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 11, 2025 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Apr 11, 2025 CHPB
ASSIGNED TO PETITION STAFF
Apr 11, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 7, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 23, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 4, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 11, 2024 GNFN
FINAL REFUSAL E-MAILED
Sep 11, 2024 GNFR
FINAL REFUSAL WRITTEN
Sep 11, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 19, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 1, 2022 AMPX
ASSIGNED TO LIE
May 27, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
May 20, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2022 NWOS
NEW APPLICATION ENTERED
May 18, 2022 NWAP

Related Trademarks

More from this Owner

SELECTIVITY AND REACTIVITY TUNING

SELECTIVITY AND REACTIVITY TUNING

START

START

PRECISION MEDICINE THROUGH NOVEL COVALENCY

PRECISION MEDICINE THROUGH NOVEL COVALENCY